Clinical trial site organization consolidation continues with the recent news that a specialized investment bank focusing on healthcare transactions known as Provident Healthcare Partners (Provident)…
NAMSAÂ is a contract research organization (CRO) that traditionally specializes in the development of medical device services, providing full-continuum development solutions. They’ve been on a hot…
The contract research organization (CRO) space continues to consolidate as just a couple weeks ago, Thermo Fisher Scientific (NYSE: TMO) announced its intention to acquire…
Trial site organizational merger and acquisition activity continues as Headlands Research recently purchased Artemis Institute for Clinical Research, representing a move by the former to strengthen…
As the clinical research space continues to adapt, advance and evolve, TrialSite chronicles a number of trends, including the ongoing entry of private equity into…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
